Quick Answer
XBiotech Inc. reported Total Assets of $150.08 million for fiscal year 2025.
XBiotech Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $150.08M | -24.6% |
| 2024 | $199.09M | -12.1% |
| 2023 | $226.62M | -7.9% |
| 2022 | $246.10M | -10.6% |
| 2021 | $275.18M | -22.2% |
| 2020 | $353.74M | -56.7% |
| 2019 | $816.88M | +1742.1% |
| 2018 | $44.34M | -29.6% |
| 2017 | $62.97M | -6.1% |
| 2016 | $67.05M | -38.7% |
| 2015 | $109.36M | +75.9% |
| 2014 | $62.18M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $172.42M | -17.8% | -3.5% |
| June 30, 2025 | $178.68M | -17.1% | -1.7% |
| March 31, 2025 | $181.86M | -20.2% | -8.7% |
| December 31, 2024 | $199.09M | -12.1% | -5.1% |
| September 30, 2024 | $209.85M | -8.6% | -2.6% |
| June 30, 2024 | $215.56M | -8.3% | -5.4% |
| March 31, 2024 | $227.86M | -5.9% | +0.5% |
| December 31, 2023 | $226.62M | -7.9% | -1.3% |
- XBiotech Inc. showed a decrease of -24.6% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, XBiotech Inc.’s total assets has grown by 141.4% (from $62.18 million to $150.08 million).
- The most recent figure is from XBiotech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: